2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.

2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.

After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer.

Berchiche is the founder of Dr. My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed

Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI Oxford Professor of Chemistry and Founder of OMass Therapeutics Wins Two International Awards Novo Nordisk moves to strengthen obesity efforts

This is a rare neurodevelopmental disorder caused by de novo mutations in the GRIN genes that encode

has led to a series of high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief Scientific Officer.

has led to a series of high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief Scientific Officer.

With a strong foundation in scientific excellence and project leadership, she thrives in fast-paced, diverse experience, including serving as a Research Fellow, Graduate Research and Teaching Assistant, Co-Founder

With a strong foundation in scientific excellence and project leadership, she thrives in fast-paced, diverse experience, including serving as a Research Fellow, Graduate Research and Teaching Assistant, Co-Founder

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator

Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.

Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.

During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and

She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.

She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

receptor signaling in the enteric nervous system is a potential treatment for gut motility disorders RTN4/NoGo-receptor OB-004 is a GPCR targeted protein analog of CCL2 that targets the CCR2 receptor OMass Therapeutics's founder Robinson, has been awarded the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert

Keck Foundation, and the John J. Abel Award from ASPET .

Jean-Philippe Pin on the web LinkedIn ResearchGate CNRS Fondation Bettencourt Schueller FRC Neurodon